Infectious Laryngotracheitis

Infectious Laryngotracheitis is a highly contagious viral respiratory disease that primarily affects chickens and causes severe inflammation and damage to the upper respiratory tract, particularly the larynx and trachea. This significant poultry disease is caused by Gallid herpesvirus 1, a member of the Herpesviridae family, and can result in substantial mortality and production losses in affected flocks. The disease has a worldwide distribution and represents one of the most economically important respiratory infections of chickens, affecting both commercial operations and backyard flocks. Chickens of all ages can be affected, though the disease tends to be most severe in mature birds, and other gallinaceous species including pheasants, peafowl, and partridges are also susceptible.

The causative agent of Infectious Laryngotracheitis is a double-stranded DNA virus that specifically targets the respiratory epithelium of susceptible birds. The virus enters through the respiratory route when susceptible birds inhale virus particles shed by infected or carrier birds. Once established in the respiratory tract, the virus replicates in the epithelial cells of the larynx, trachea, and sometimes the conjunctiva and nasal passages, causing severe inflammation, cell death, and the formation of bloody mucus that can obstruct the airway. A particularly concerning feature of this herpesvirus is its ability to establish latent infections in recovered birds, which can later reactivate and shed virus during periods of stress, perpetuating the cycle of transmission within and between flocks.

The impact of Infectious Laryngotracheitis on poultry health and welfare is substantial, with clinical disease ranging from mild respiratory signs to severe, life-threatening airway obstruction. In its most severe form, the disease causes birds to struggle for breath, extend their necks, and produce gurgling or gasping sounds as they attempt to move air past bloody obstructions in their airways. Mortality in acute outbreaks can reach fifty percent or higher in unvaccinated flocks, and even birds that survive often experience prolonged recovery periods with significant production losses. The economic consequences include not only direct mortality but also reduced egg production, decreased growth rates, increased susceptibility to secondary infections, and the costs associated with implementing control measures.

While no specific antiviral treatment exists for Infectious Laryngotracheitis, the disease can be managed through supportive care and appropriate biosecurity measures, with vaccination serving as the primary tool for prevention in endemic areas. Early recognition of the disease is crucial for implementing control measures that limit spread within and between flocks, as the virus is highly contagious during the acute phase of infection. Birds that recover from natural infection develop immunity but may harbor latent virus that can reactivate under stress. Prevention through vaccination and biosecurity is far preferable to dealing with an outbreak, and working with an avian veterinarian to develop appropriate prevention strategies is essential for protecting poultry flocks in areas where Infectious Laryngotracheitis occurs.

The primary cause of Infectious Laryngotracheitis is infection with Gallid herpesvirus 1, also known as Infectious Laryngotracheitis Virus, a member of the subfamily Alphaherpesvirinae within the family Herpesviridae. This double-stranded DNA virus is highly adapted to infecting the respiratory epithelium of chickens and related gallinaceous birds. Like other herpesviruses, it has the ability to establish lifelong latent infections in recovered birds, with the trigeminal ganglia serving as the primary site of viral latency. Strains of the virus vary in virulence, with some causing severe disease with high mortality while others produce milder respiratory signs. The virus is moderately stable in the environment and can survive in contaminated material for days to weeks under cool, moist conditions.

Species susceptibility to Infectious Laryngotracheitis is primarily limited to gallinaceous birds, with chickens being the most clinically affected species. Pheasants, peafowl, partridges, and guinea fowl can also become infected and develop clinical disease, though the severity may differ from that seen in chickens. Turkeys appear to be resistant to infection under natural conditions. Among chickens, there does not appear to be significant genetic variation in susceptibility between different breeds or production types, though birds with prior respiratory disease or concurrent infections may experience more severe clinical signs. Age at infection influences disease presentation, with older chickens often showing more severe respiratory distress than younger birds, possibly due to differences in airway diameter and response to inflammation.

Environmental and management factors play crucial roles in the transmission and severity of Infectious Laryngotracheitis outbreaks. The virus spreads primarily through respiratory aerosols produced by infected birds coughing and sneezing, with close contact between birds facilitating transmission. Contaminated equipment, footwear, clothing, and vehicles can mechanically transport virus between farms, making biosecurity failures a major risk factor for disease introduction. Poor ventilation in poultry houses increases respiratory pathogen concentration in the air and facilitates transmission between birds. Stress from overcrowding, temperature extremes, poor air quality, or concurrent disease increases both susceptibility to infection and the likelihood of latent virus reactivation in carrier birds.

Several risk factors increase the likelihood and severity of Infectious Laryngotracheitis in poultry operations. Proximity to other poultry farms, particularly those with a history of ILT, increases risk of virus introduction. Multi-age production systems create opportunities for virus to cycle continuously as recovered carriers contact susceptible young birds. Introduction of birds of unknown health status, including exhibition birds returning from shows, can introduce the virus to naive flocks. Areas with high poultry density tend to have endemic ILT with ongoing virus circulation. The use of live attenuated ILT vaccines, while protective, can also contribute to virus circulation as vaccine strains can revert to virulence and spread to unvaccinated birds.

The mechanism by which Infectious Laryngotracheitis Virus causes disease involves direct destruction of respiratory epithelial cells and a robust inflammatory response. After inhalation, virus particles attach to and enter epithelial cells lining the trachea and larynx. Viral replication within these cells causes cell death and sloughing of the epithelial lining. The host inflammatory response brings fluid, mucus, and blood into the airway, creating the characteristic bloody exudate seen in severe cases. The combination of epithelial destruction and inflammatory exudate can partially or completely obstruct the airway, causing the respiratory distress and gasping characteristic of the disease. During recovery, epithelial regeneration occurs, but the virus retreats into sensory nerve ganglia where it establishes latency and can later reactivate, causing recurrent virus shedding without necessarily producing clinical disease.

The early warning signs of Infectious Laryngotracheitis may be subtle initially but typically progress rapidly to more obvious respiratory distress. In the first days of infection, affected birds may show mild respiratory sounds such as occasional snicking or slight nasal discharge. Subtle changes in vocalization may be noticed, with birds sounding slightly hoarse or making quieter sounds than normal. A mild decrease in feed consumption and slight lethargy may precede more obvious respiratory signs. Some birds develop watery eyes or mild conjunctivitis early in the course of infection, as the virus can also affect the conjunctival epithelium. These early signs can easily be attributed to mild respiratory irritation or other causes, making vigilant observation essential for early detection.

As the disease progresses, common symptoms become dramatically apparent and include severe respiratory distress that is difficult to miss. Affected birds show obvious difficulty breathing, with characteristic neck extension as they gasp for air. A gurgling or rattling sound may be heard as birds attempt to breathe through airways partially blocked by bloody mucus. Birds may cough up blood-tinged mucus, and bloody discharge may be visible around the nares and beak. The respiratory rate increases significantly, and birds may breathe with open mouths. Head shaking is common as birds attempt to clear their airways. In laying flocks, egg production drops sharply, often by thirty to fifty percent or more within the first week of an outbreak.

Behavioral changes in birds affected by Infectious Laryngotracheitis reflect the severe respiratory distress and systemic illness they experience. Infected birds become markedly depressed and reluctant to move, often sitting with eyes closed and feathers ruffled. Appetite and water consumption decrease dramatically as the effort of breathing takes precedence over other activities. Affected birds separate from the flock and seek quiet areas where they can rest undisturbed. Normal behaviors such as foraging, dust bathing, and vocalizing cease as birds conserve energy for breathing. Some birds may hold their heads in unusual positions in an attempt to maximize airway opening and facilitate breathing.

Physical signs visible on examination of birds with Infectious Laryngotracheitis provide important diagnostic clues. The conjunctiva may appear reddened and swollen, with excessive tearing or mucoid discharge. Nasal discharge ranges from clear to bloody depending on disease severity. Opening the beak reveals blood-tinged mucus in the oral cavity and pharynx. The feathers around the face may be matted with dried discharge. Affected birds often show cyanosis, a bluish discoloration of the comb, wattles, and visible skin, indicating inadequate oxygenation due to respiratory obstruction. Postmortem examination reveals severe hemorrhagic inflammation of the trachea with caseous or bloody exudate, and in severe cases, complete obstruction of the airway with clotted blood and fibrinous material.

The progression of symptoms in Infectious Laryngotracheitis follows a characteristic timeline from initial infection to peak disease and eventual recovery or death. Clinical signs typically appear six to twelve days after exposure to the virus, though the incubation period can range from five to fourteen days. Once clinical signs begin, disease spreads rapidly through a flock over the course of one to two weeks. Mortality occurs most heavily during the second week of an outbreak, with affected birds either dying from asphyxiation or beginning to show improvement as airway lesions start to heal. The acute phase of the disease generally lasts two to four weeks in a flock, after which surviving birds gradually recover over several additional weeks.

Certain symptoms of Infectious Laryngotracheitis require immediate veterinary attention to maximize survival and minimize flock losses. Any bird showing severe respiratory distress with gasping, open-mouth breathing, or bloody discharge from the mouth or nares needs urgent assessment. Sudden onset of respiratory disease spreading rapidly through a flock should trigger immediate veterinary investigation. Birds showing cyanosis of the comb and wattles indicate life-threatening respiratory compromise requiring intervention. Dramatic drops in egg production combined with respiratory signs warrant prompt diagnostic workup. Any suspicion of ILT should prompt immediate implementation of enhanced biosecurity to prevent spread to other poultry on the premises or neighboring farms.

The initial examination for suspected Infectious Laryngotracheitis involves gathering detailed history and performing thorough physical examination of affected birds. An avian veterinarian will inquire about the onset and progression of clinical signs, the percentage of birds affected, mortality rates, vaccination history, and any recent bird introductions or potential exposure events. Physical examination focuses on the respiratory system, including listening for abnormal breathing sounds, examining the nares and oral cavity for discharge, and assessing conjunctival health. The severity of respiratory distress is evaluated, noting whether birds are extending their necks, breathing with open mouths, or showing cyanosis. The pattern of disease spread within the flock provides epidemiological clues that help differentiate ILT from other respiratory conditions.

Diagnostic testing for Infectious Laryngotracheitis utilizes several laboratory methods to confirm the presence of the virus. Postmortem examination of birds that have died or been euthanized reveals characteristic gross lesions including severe hemorrhagic tracheitis with blood clots and fibrinous exudate in the tracheal lumen. Histopathological examination of tracheal tissue shows epithelial hyperplasia and necrosis with intranuclear inclusion bodies in infected cells. Polymerase chain reaction testing of tracheal swabs or tissue samples provides rapid and sensitive detection of viral genetic material. Virus isolation in embryonated chicken eggs or cell culture can be performed but is slower and less commonly used for routine diagnosis. Serological testing to detect antibodies against ILT virus helps confirm recent infection, particularly when paired serum samples show rising antibody titers.

Differential diagnosis is essential because several other respiratory diseases of poultry can produce clinical signs similar to Infectious Laryngotracheitis. Infectious bronchitis causes respiratory signs and production drops but typically produces less severe hemorrhagic tracheitis. Avian influenza can cause severe respiratory disease with hemorrhagic lesions and must be ruled out due to its regulatory significance. Newcastle disease produces respiratory and neurological signs and is another important rule-out. Mycoplasma gallisepticum causes chronic respiratory disease with conjunctivitis and sinusitis. Aspergillosis can cause similar gasping behavior but tends to affect the lower respiratory tract and air sacs. The avian veterinarian considers the specific pattern of clinical signs, gross lesions, and laboratory results to differentiate ILT from these other conditions.

Confirmation of Infectious Laryngotracheitis diagnosis is achieved through combination of compatible clinical signs, characteristic gross and microscopic lesions, and positive laboratory testing for the virus. The presence of severe hemorrhagic tracheitis with intranuclear inclusion bodies on histopathology is highly suggestive of ILT. Positive PCR detection of ILT virus genetic material in tracheal samples provides definitive laboratory confirmation. Virus isolation, while less commonly performed, represents the gold standard for confirming the presence of viable virus. Once ILT is confirmed, molecular typing may be performed to determine whether the causative strain is a field virus or a vaccine-derived strain, which has implications for epidemiological investigation and future vaccination strategies.

Emergency and immediate treatment for birds affected by Infectious Laryngotracheitis focuses on supportive care and relief of respiratory distress, as no specific antiviral therapy is available. Birds showing severe respiratory compromise may benefit from gentle removal of accumulated mucus and blood from the trachea, though this procedure carries risks and should only be performed by experienced personnel. Providing a warm, humid environment helps thin respiratory secretions and ease breathing. Reducing environmental stressors such as dust, ammonia from litter, and temperature extremes minimizes additional respiratory irritation. Severely affected birds should be handled minimally to avoid exacerbating respiratory distress. Isolation of clinically affected birds from healthy flockmates reduces ongoing virus transmission, though given the rapid spread of ILT, most birds in a flock may already be exposed by the time clinical signs are recognized.

Medical management of Infectious Laryngotracheitis primarily involves controlling secondary bacterial infections that commonly complicate viral respiratory damage. Broad-spectrum antibiotics administered through drinking water or feed help prevent or treat opportunistic bacterial colonization of the damaged respiratory tract. Common secondary pathogens include Escherichia coli, Pasteurella species, and Ornithobacterium rhinotracheale. Vitamin supplementation, particularly vitamins A and E, may support epithelial healing and immune function. Anti-inflammatory medications are sometimes used to reduce airway swelling and improve breathing, though their efficacy specifically for ILT is not well established. All medications should be used under veterinary guidance with appropriate attention to withdrawal periods for birds in food production.

Surgical intervention for Infectious Laryngotracheitis is rarely performed but may occasionally be considered in valuable individual birds with life-threatening airway obstruction. Emergency tracheotomy, creating an opening in the trachea below the obstructed area to allow breathing, has been performed in some cases, though this is a salvage procedure with significant risks and complications. Removal of accumulated debris from the trachea may be attempted in valuable birds, but the procedure is stressful and may cause additional damage to the fragile respiratory epithelium. For most production situations, surgical intervention is not practical or economically justified. Severely affected birds that are unlikely to survive or recover productively are often humanely euthanized to prevent further suffering.

Supportive care forms the cornerstone of treatment for Infectious Laryngotracheitis and significantly influences survival rates. Maintaining adequate hydration is essential, and electrolyte-supplemented water should be readily available. Some birds may need to be encouraged to drink or may require fluid administration by other routes if they are too dyspneic to drink normally. Providing highly palatable, easily consumed feed supports nutritional status during illness. Environmental temperature should be maintained in the thermoneutral zone to reduce metabolic demands and stress. Excellent air quality with minimal dust and ammonia reduces irritation of the damaged respiratory tract. Reducing stocking density gives individual birds better access to feed and water and reduces pathogen concentration in the air.

Complementary approaches to Infectious Laryngotracheitis management may provide some benefit alongside standard supportive care. Nebulization with saline or mucolytic agents can help thin respiratory secretions and improve airway clearance. Some producers use expectorants to facilitate mucus clearance from the airways. Herbal preparations with purported respiratory or immune benefits are sometimes used in alternative poultry medicine, though scientific evidence for their efficacy against ILT is lacking. Probiotic supplementation may help maintain gut health and support overall immune function during recovery. Any complementary treatments should be discussed with an avian veterinarian to ensure they do not interfere with conventional care or create food safety concerns.

Treatment decisions for Infectious Laryngotracheitis must consider multiple factors including flock size, production type, and available resources. In large commercial flocks, treatment is typically limited to flock-level interventions such as water medication and environmental optimization, with individual bird care not being economically practical. For small backyard flocks or valuable breeding birds, more intensive individual care including fluid therapy and manual airway clearance may be justified. The severity of the outbreak influences prognosis and guides treatment intensity decisions. Prevention through vaccination in endemic areas is generally far more effective and economical than attempting to treat clinical disease. Consultation with an avian veterinarian helps flock owners make informed decisions about treatment approaches and realistic expectations for outcomes.

The recovery timeline for birds that survive Infectious Laryngotracheitis varies depending on disease severity and the quality of supportive care provided. Clinical improvement typically begins around two to three weeks after the onset of symptoms, as the inflammatory response subsides and the respiratory epithelium begins to regenerate. Full recovery of the tracheal epithelium may take four to six weeks or longer. During this healing period, birds gradually regain normal breathing patterns and resume normal eating and drinking behavior. However, even after apparent clinical recovery, birds remain latently infected with the virus and can potentially reactivate and shed virus during periods of stress for the remainder of their lives.

Post-treatment care for flocks recovering from Infectious Laryngotracheitis requires ongoing attention to respiratory health and biosecurity. Continued provision of clean, dust-free environments supports respiratory healing and reduces irritation. Secondary bacterial infections may develop during the recovery period as the damaged epithelium is susceptible to opportunistic colonization, requiring monitoring and potential antibiotic treatment. Gradual return to normal feeding and management routines helps birds regain condition without excessive stress. Biosecurity measures must be maintained to prevent spread to other susceptible flocks on the premises or neighboring properties. Recovered birds should be considered potential carriers for life and managed accordingly.

Prognosis for birds recovering from Infectious Laryngotracheitis depends on several factors including disease severity, secondary complications, and production goals. Birds that survive the acute phase without severe respiratory damage generally have good long-term survival, though they remain latently infected. Mortality during acute outbreaks typically ranges from ten to thirty percent with classical strains but can exceed fifty percent with severe strains or in naive, unvaccinated flocks. Laying hens often take several weeks to months to return to pre-outbreak production levels, and some birds may never fully recover their laying potential. Birds that suffered severe airway damage may have persistent respiratory abnormalities affecting their long-term productivity and quality of life.

The long-term outlook for flocks that have experienced Infectious Laryngotracheitis includes important implications for future management. All recovered birds should be considered latent carriers with the potential to reactivate and shed virus, particularly during stress. This carrier status means that mixing recovered birds with naive birds can result in disease transmission. Maintaining recovered birds as an isolated, closed flock until depopulation and thorough cleaning and disinfection before repopulation is often recommended. Future flocks introduced to premises with a history of ILT should be vaccinated prior to introduction. The economic impact of an ILT outbreak extends beyond immediate mortality and production losses to include ongoing management restrictions and the costs of implementing enhanced biosecurity and vaccination programs.

Environmental prevention of Infectious Laryngotracheitis relies heavily on biosecurity measures designed to prevent virus introduction and limit spread if infection occurs. Poultry houses and equipment should be thoroughly cleaned and disinfected between flocks, with particular attention to removing organic material that can protect the virus from disinfectants. The ILT virus is susceptible to most common disinfectants including quaternary ammonium compounds, phenolic compounds, and oxidizing agents when applied to clean surfaces. All-in-all-out management, where complete depopulation is followed by thorough cleaning before introducing new birds, helps break cycles of infection. Controlling access to poultry areas and implementing footwear and clothing changes or disinfection for all personnel reduces mechanical transmission risk. Insect and rodent control programs eliminate potential mechanical vectors.

Quarantine protocols are essential for preventing introduction of Infectious Laryngotracheitis into naive flocks. New birds should be isolated for a minimum of three to four weeks before introduction to existing flocks, allowing time for any incubating infections to become apparent. During quarantine, birds should be monitored closely for any respiratory signs that might indicate ILT infection. Birds returning from poultry shows or exhibitions should be quarantined before rejoining home flocks, as shows are potential sources of disease exposure. Ideally, replacement birds should be sourced from ILT-free flocks with documented health status. Any birds showing respiratory signs during quarantine should be examined by an avian veterinarian before decisions about flock introduction are made.

Dietary considerations for Infectious Laryngotracheitis prevention focus on supporting optimal immune function and respiratory health through proper nutrition. Balanced diets meeting all nutritional requirements support robust immune system function and mucosal defenses. Adequate levels of vitamin A are particularly important for maintaining healthy respiratory epithelium and providing first-line defense against respiratory pathogens. Vitamin E and selenium support immune cell function and antioxidant defenses. Avoiding feed contamination with mycotoxins is essential, as some mycotoxins are immunosuppressive and others specifically damage respiratory epithelium. Clean, fresh water free of bacterial contamination supports overall health and helps maintain adequate hydration of respiratory mucous membranes.

Vaccination is the primary tool for Infectious Laryngotracheitis prevention in endemic areas and is highly effective when properly implemented. Several vaccine types are available, including live attenuated vaccines administered by eye drop, drinking water, or spray, and recombinant vector vaccines that express ILT virus proteins. Live vaccines vary in virulence and immunogenicity, with more attenuated vaccines being safer but potentially less effective, while less attenuated vaccines provide stronger immunity but carry greater risk of reversion to virulence and spread. Vaccination programs should be designed by an avian veterinarian based on local disease pressure, flock type, and available vaccine options. In areas where ILT is not endemic, vaccination may not be recommended, as it can introduce the virus to a region if vaccine strains spread to unvaccinated birds.

Early intervention and proactive health management enhance ILT prevention success and minimize the impact of any outbreaks that occur. Regular monitoring of flock health through observation and performance tracking allows early detection of respiratory problems. Establishing baseline respiratory health parameters makes it easier to recognize deviations that might indicate disease. Maintaining good relationships with neighboring poultry operations facilitates communication about disease events that might pose a risk. Staying informed about ILT occurrence in the region through industry contacts, veterinary networks, and extension services allows timely adjustment of prevention strategies. Developing a written disease response plan in advance ensures rapid, organized response if an outbreak is suspected.

Daily management of flocks affected by or recovering from Infectious Laryngotracheitis requires consistent attention to respiratory health and supportive care needs. Fresh feed and water should be provided at least twice daily, with careful monitoring of consumption to detect any decrease that might signal recurring respiratory problems. Birds on antibiotic treatment for secondary infections must receive medication consistently according to veterinary instructions. Daily observation should include listening for abnormal respiratory sounds that might indicate complications or recurrence. Activity levels, feeding behavior, and respiratory effort should be noted and any concerning changes investigated promptly. Maintaining good air quality with adequate ventilation while avoiding drafts is essential during the recovery period.

The home environment for birds that have experienced Infectious Laryngotracheitis may require modifications to support respiratory health. Excellent ventilation is critical for maintaining air quality while avoiding cold drafts that could stress recovering birds. Dust control through proper litter management, avoiding dusty feeds, and maintaining appropriate humidity levels reduces respiratory irritation. Temperature should be maintained in a comfortable range to minimize metabolic stress on recovering birds. Ammonia levels from litter decomposition must be controlled through regular removal of wet litter and adequate ventilation, as ammonia damages respiratory epithelium and predisposes to secondary infections. Perches and roosts should be positioned to allow adequate airflow around resting birds.

Maintaining quality of life for birds that have survived Infectious Laryngotracheitis involves supporting their recovery while accommodating any lasting respiratory limitations. Birds recovering from severe disease should be allowed to rest and gradually resume normal activity as their breathing improves. Access to fresh air and outdoor areas, where available and biosecurity permits, may be beneficial for respiratory health. Social housing with compatible flockmates provides behavioral enrichment, but overcrowding must be avoided to minimize respiratory pathogen transmission. Monitoring individual birds for signs of chronic respiratory compromise helps identify those that may need special accommodation or consideration for humane culling if quality of life cannot be maintained.

Ongoing monitoring and veterinary care are essential components of managing flocks with a history of Infectious Laryngotracheitis. Regular observation for respiratory abnormalities helps detect secondary infections or disease recurrence early. Tracking egg production in laying flocks provides an objective measure of flock health and recovery progress. Scheduling periodic check-ups with an avian veterinarian allows professional assessment and early intervention for any problems. Recording any respiratory events, treatments administered, and outcomes builds a history that informs future management decisions. Maintaining detailed vaccination records and ensuring timely revaccination as recommended protects against future outbreaks.

Caregiver support for poultry keepers managing ILT-affected flocks encompasses practical resources and emotional considerations. The financial impact of ILT outbreaks can be substantial, including mortality losses, reduced production, treatment costs, and enhanced biosecurity expenses. Connecting with agricultural extension services, veterinary colleges, and producer organizations provides access to technical guidance and support programs. The stress of managing disease outbreaks and making difficult decisions about bird welfare can be emotionally challenging, and connecting with other poultry keepers through local clubs or online communities provides peer support and shared experience. Understanding that ILT can be managed effectively through appropriate prevention measures in the future helps caregivers maintain perspective and move forward constructively after an outbreak.

Chickens are by far the species most affected by Infectious Laryngotracheitis, with both commercial and backyard flocks fully susceptible to the disease. The virus causes clinical disease in chickens of all ages, though the severity and presentation may vary. Mature chickens often develop more severe respiratory signs than young birds, possibly due to differences in airway anatomy and immune response. All types of chickens including layer, broiler, breeder, and backyard dual-purpose birds are susceptible. There does not appear to be significant variation in susceptibility among different chicken breeds, though birds with compromised respiratory systems due to concurrent infection or environmental factors may experience more severe disease.

Beyond chickens, several other gallinaceous bird species are susceptible to Infectious Laryngotracheitis with varying degrees of clinical disease. Pheasants are susceptible and can develop clinical disease similar to that seen in chickens. Peafowl can become infected and may show respiratory signs ranging from mild to severe. Partridges and guinea fowl have also been shown to be susceptible to infection. Turkeys are generally considered resistant to ILT virus infection under natural conditions, though experimental infection is possible. Waterfowl and non-gallinaceous species are not susceptible to the virus. These susceptible gallinaceous species may serve as sources of infection for chicken flocks and should be considered in biosecurity planning.

Screening and surveillance recommendations for Infectious Laryngotracheitis focus on detection of virus circulation and assessment of flock immunity status. Regular serological monitoring of flocks in endemic areas helps track the effectiveness of vaccination programs and detect potential subclinical infections. In areas considered ILT-free, surveillance testing of flocks with any unexplained respiratory signs helps detect new introductions early. Testing of birds before movement or sale helps prevent spread to new areas or flocks. Poultry exhibitors should be particularly vigilant about health screening before and after shows where birds from multiple sources commingle. Working with state or provincial veterinary authorities and poultry industry organizations facilitates coordinated surveillance and rapid response to new outbreaks.

Several conditions commonly occur alongside Infectious Laryngotracheitis or develop as complications, compounding the impact on affected birds. Secondary bacterial infections are extremely common as opportunistic pathogens colonize respiratory tissue damaged by the virus. Escherichia coli, Ornithobacterium rhinotracheale, and Pasteurella multocida are frequently isolated from birds with complicated ILT. Concurrent infection with Mycoplasma gallisepticum can worsen respiratory disease severity and prolong recovery. Aspergillosis may develop as a secondary fungal infection in severely immunocompromised birds. Concurrent infection with immunosuppressive viruses such as Infectious Bursal Disease Virus or Chicken Anemia Virus can worsen ILT severity and outcomes.

Several respiratory conditions produce clinical signs similar to Infectious Laryngotracheitis and must be differentiated through diagnostic testing. Infectious bronchitis causes respiratory signs and production drops but typically produces less hemorrhagic tracheal lesions. Avian influenza can cause severe respiratory disease with high mortality and must be ruled out due to its reportable disease status. Newcastle disease produces respiratory and sometimes neurological signs and is another important differential. Mycoplasmosis causes chronic respiratory disease with conjunctivitis and sinusitis. Aspergillosis produces respiratory distress but typically affects the lower respiratory tract and air sacs. Accurate differentiation relies on laboratory testing including PCR, virus isolation, and histopathology, as clinical signs alone are often insufficient to distinguish between these conditions.

Complications of Infectious Laryngotracheitis can develop during acute disease or persist after apparent recovery. Asphyxiation from airway obstruction with bloody exudate is the primary cause of death during acute outbreaks. Secondary bacterial septicemia can develop when opportunistic pathogens invade through damaged respiratory epithelium. Chronic respiratory impairment may persist in birds that suffered severe tracheal damage, affecting their long-term productivity and quality of life. Latent carrier status in recovered birds represents an ongoing complication that can lead to virus reactivation and transmission to susceptible contacts. Secondary aspergillosis may develop in severely affected birds with compromised respiratory defenses, causing additional respiratory compromise.